Cell-free, immuno-stimulatory DNA is recognized in the cytoplasm of cells as a universal danger signal by the innate immune system. We are using genome-scale RNAi and CRISPR/Cas9 approaches in primary human cells to identify important new players in the cGAS-STING pathway of innate cytoplasmic DNA sensing, which has been implicated as the primary sensor for many fungal, bacterial, viral pathogens, and even for neoplastic cells. We aniticpate that key regulators of this pathway will represent important targets for boosting innate immune responses to microbial pathogens and cancer.
New Molecular Players in the cGAS-STING Pathway of Anti-Viral and Anti-Tumor Defense
About La Jolla Institute
The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease. Visit lji.org for more information.
Share this Article:
- Research News
Scientists show how a mutated gene harms red and white blood cells
- Research News
New LJI research suggests many people already have T cells with the power to fight "highly pathogenic" avian influenza
- Institute News
U.S. and Italian scientists team up to advance immune system research
